Loading…

Discovery and characterization of a novel 7-aminopyrazolo[1,5-a]pyrimidine analog as a potent hepatitis C virus inhibitor

A series of 7-aminopyrazolo[1,5-a]pyrimidine (7-APP) derivatives was screened via phenotypic cell-based assay. Among the compounds tested, compound 32 turned out to be the most promising with 0.28μM EC50 value in the infectious HCVcc. We describe a novel 7-aminopyrazolo[1,5-a]pyrimidine (7-APP) deri...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters 2012-12, Vol.22 (24), p.7297-7301
Main Authors: Hwang, Jong Yeon, Windisch, Marc Peter, Jo, Suyeon, Kim, Keumhyun, Kong, Sunju, Kim, Hyoung Cheul, Kim, Soohyun, Kim, Heeyoung, Lee, Myung Eun, Kim, Youngmi, Choi, Jihyun, Park, Dong-Sik, Park, Eunjung, Kwon, Jeongjin, Nam, Jiyoun, Ahn, Sujin, Cechetto, Jonathan, Kim, Junwon, Liuzzi, Michel, No, Zaesung, Lee, Jinhwa
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A series of 7-aminopyrazolo[1,5-a]pyrimidine (7-APP) derivatives was screened via phenotypic cell-based assay. Among the compounds tested, compound 32 turned out to be the most promising with 0.28μM EC50 value in the infectious HCVcc. We describe a novel 7-aminopyrazolo[1,5-a]pyrimidine (7-APP) derivative as a potent hepatitis C virus (HCV) inhibitor. A series of 7-APPs was synthesized and evaluated for inhibitory activity against HCV in different cell culture systems. The synthesis and preliminary structure-activity relationship study of 7-APP are reported.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2012.10.123